Article Information
History
- October 13, 2020.
Article Versions
- You are currently viewing Version 1 of this article (October 13, 2020 - 10:00).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- RM Stuart1,2,†,
- Romesh G. Abeysuriya2,
- Cliff C. Kerr3,4,
- Dina Mistry3,
- Daniel J. Klein3,
- Richard Gray5,
- Margaret Hellard2,6,7,8,9 and
- Nick Scott2,6
- 1Department of Mathematical Sciences, University of Copenhagen, Copenhagen, Denmark
- 2Disease Elimination Program, Burnet Institute, Melbourne, Victoria, Australia
- 3Institute for Disease Modeling, Global Health Division, Bill & Melinda Gates Foundation, Seattle, USA
- 4School of Physics, University of Sydney, Sydney, New South Wales, Australia
- 5The Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia
- 6School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
- 7University of Melbourne, Parkville, Victoria, Australia
- 8Department of Infectious Diseases, The Alfred Hospital and Monash University, Melbourne, Victoria, Australia
- 9The School of Population and Global Health and the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
- ↵†Corresponding author. E-mail: robyn{at}math.ku.dk
Posted October 13, 2020.
Robust test and trace strategies can prevent COVID-19 resurgences: a case study from New South Wales, Australia
